Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. IJ Pharmaceutical Research
  4. Articles

  5. Brain-derived Neurotrophic Factor and Its Applications through Nanosystem Delivery
  6. Crossref

IJ Pharmaceutical Research

Home
Current IssueAll IssuesIn PressAccepted Manuscripts
SearchInstructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref


1. The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review

- Elżbieta Cecerska-Heryć

- Maja Pękała

- Natalia Serwin

- Marta Gliźniewicz

- Bartłomiej Grygorcewicz

- Anna Michalczyk

- Rafał Heryć

- Marta Budkowska

- Barbara Dołęgowska

2. Prefrontal Cortical Projection Neurons: Involvement in Shaping Different Types of Behaviors, BDNF Expression and Transport

- U. S. Drozd

- Ya. A. Frik

- A. V. Smagin

- D. A. Lanshakov

3. Oleanolic acid-based therapeutics ameliorate rotenone-induced motor and depressive behaviors in parkinsonian male mice via controlling neuroinflammation and activating Nrf2-BDNF-dopaminergic signaling pathways

- Tanvi Dayanand Pingale

- Girdhari Lal Gupta

HomeSearchInstructionsAPC

Archives

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.